Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis

Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density

(2015) Charalampos Tsentidis et al.   PEDIATRIC DIABETES

Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes

(2014) Melina B. Loureiro et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Biochemical markers of bone turnover in diabetes patients—a meta-analysis, and a methodological study on the effects of glucose on bone markers

(2014) J. Starup-Linde et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporosis, Fractures, and Diabetes

(2014) Peter Jackuliak et al.   International Journal of Endocrinology

Diabetes Mellitus and Osteoporosis

(2013) Robert Sealand et al.   Current Diabetes Reports

Evaluation of bone mineral density in children with type 1 diabetes mellitus

(2013) Asan Onder et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus

(2013) Irene Lambrinoudaki et al.   International Journal of Endocrinology

Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: Relationship to microvascular complications and bone mineral density

(2012) Mohammed A. AboElAsrar et al.   CYTOKINE

Biochemical Markers of Bone Cell Activity in Children with Type 1 Diabetes Mellitus

(2011) A. Pater et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients

(2011) Soha M. Abd El Dayem et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Mechanisms of impaired bone strength in type 1 and 2 diabetes

(2010) D. Merlotti et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Poster Sessions

(2010)   PEDIATRIC DIABETES

Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus

(2009) Bradley J. Van Sickle et al.   CYTOKINE

Lower bone mineral density in children with type 1 diabetes is associated with poor glycemic control and higher serum ICAM-1 and urinary isoprostane levels

(2009) Kaire Heilman et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Osteoporosis among patients with type 1 and type 2 diabetes

(2008) A. Räkel et al.   DIABETES & METABOLISM

Young Women With Type 1 Diabetes Have Lower Bone Mineral Density That Persists Over Time

(2008) L. D. Mastrandrea et al.   DIABETES CARE

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

(2008) Ann E. Kearns et al.   ENDOCRINE REVIEWS

IGF-1 and IGF-Binding Proteins and Bone Mass, Geometry, and Strength: Relation to Metabolic Control in Adolescent Girls With Type 1 Diabetes

(2008) Laurie J Moyer-Mileur et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Evolución de la masa ósea durante la infancia y adolescencia en niños con diabetes mellitus tipo 1

(2008) María de los Ángeles Vázquez Gámez et al.   MEDICINA CLINICA

Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers

(2008) M. T. Saha et al.   OSTEOPOROSIS INTERNATIONAL